Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance"

被引：0
|
作者：
Yip, Terry Cheuk-Fung [1 ,2 ]
Chan, Henry Lik-Yuen [1 ,2 ,3 ]
Wong, Vincent Wai-Sun [1 ,2 ,3 ]
Wong, Grace Lai-Hung [1 ,2 ,3 ]
机构：
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 01期
关键词：
CARRIERS; SCORES;
D O I：
10.1016/j.jhep.2017.08.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：208 / 209
页数：3
相关论文
共 50 条
  • [41] Risk prediction model for hepatocellular carcinoma after hepatitis b e antigen seroclearance in patients treated with entecavir or tenofovir
    Lim, Tae Seop
    Jeon, Mi Young
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seung Up
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E264 - E264
  • [42] Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg)
    Shimada, S
    Aizawa, R
    Abe, H
    Suto, S
    Miyakawa, Y
    Alzawa, Y
    INTERNAL MEDICINE, 2003, 42 (05) : 389 - 393
  • [43] Risk factors for hepatocellular carcinoma in hepatitis B surface antigen positive carriers.
    Moon, CM
    Han, KH
    Song, KJ
    Ahn, SH
    Choi, JW
    Paik, YH
    Kim, DK
    Myung, SM
    Chon, CY
    Moon, YM
    HEPATOLOGY, 2003, 38 (04) : 693A - 693A
  • [44] THE RISK OF HEPATOCELLULAR CARCINOMA IS EQUALLY LOW AFTER SPONTANEOUS AND NUCLEOS(T)IDE ANALOGUES-INDUCED HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Yip, Terry Cheuk-Fung
    Wong, Vincent Wai-Sun
    Tse, Yee-Kit
    Chan, Henry Lik Yuen
    Wong, Grace L.
    HEPATOLOGY, 2019, 70 : 105A - 106A
  • [45] Seroclearance of Hepatitis B surface antigen after entecavir treatment
    Halichidis, Stela
    Dumea, Elena
    Cambrea, Claudia S.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2013, 22 (02) : 236 - 236
  • [46] Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
    Liu, Jessica
    Yang, Hwai-I
    Lee, Mei-Hsuan
    Lu, Sheng-Nan
    Jen, Chin-Lan
    Batrla-Utermann, Richard
    Wang, Li-Yu
    You, San-Lin
    Hsiao, Chuhsing K.
    Chen, Pei-Jer
    Chen, Chien-Jen
    GUT, 2014, 63 (10) : 1648 - 1657
  • [47] Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
    Yu, Ming-Whei
    Lin, Chih-Lin
    Liu, Chun-Jen
    Wu, Wan-Jung
    Hu, Jui-Ting
    Huang, Yi-Wen
    CANCERS, 2022, 14 (23)
  • [48] Hepatitis B Surface Antigen Seroclearance: Relationship to Hepatitis B e-Antigen Seroclearance and Hepatitis B e-Antigen-Negative Hepatitis
    Fung, James
    Wong, Danny Ka-Ho
    Seto, Wai-Kay
    Kopaniszen, Maggie
    Lai, Ching-Lung
    Yuen, Man-Fung
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (11): : 1764 - 1770
  • [49] HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE RATES AND ASSOCIATED FACTORS IN CHRONIC HEPATITIS B INFECTION
    Yapali, S.
    Bayrakci, B.
    Akyildiz, M.
    Vardar, R.
    Gunsar, F.
    Ersoz, G.
    Karasu, Z.
    Ilter, T.
    Akarca, U. S.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S287 - S287
  • [50] Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
    Liu, F.
    Wang, X. -W.
    Chen, L.
    Hu, P.
    Ren, H.
    Hu, H. -D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (12) : 1253 - 1261
12345